AHCO · NASDAQ
AdaptHealth (AHCO) Stock Price & Fundamentals
AdaptHealth (AHCO) closed at $213.78 on Oct 9, 2026, down 0.33% from the previous close of $214.48.
Share price, past year
1Y −1.74%Monthly closing prices
| Date | Close |
|---|---|
| Oct 9, 2026 | $213.78 |
| Sep 30, 2026 | $215.33 |
| Aug 31, 2026 | $217.27 |
| Jul 31, 2026 | $202.83 |
| Jun 30, 2026 | $198.56 |
| May 29, 2026 | $189.22 |
| Apr 30, 2026 | $195.87 |
| Mar 31, 2026 | $207.87 |
| Feb 27, 2026 | $211.66 |
| Jan 30, 2026 | $208.23 |
| Dec 31, 2025 | $208.71 |
| Nov 28, 2025 | $211.10 |
| Oct 31, 2025 | $217.60 |
Key statistics
- Market cap
- $29.14B
- P/E (TTM)
- —
- EPS (TTM)
- −$1.68
- Revenue (TTM)
- $3.37B
- Net income (TTM)
- −$228.23M
- Shares outstanding
- 136.3M
- Dividend yield
- —
- 52-week range
- $184.00 – $224.78
AdaptHealth's market cap is $29.14B, based on a share price of $213.78 and 136.3M shares outstanding as of Jun 30, 2026.
Financials
AdaptHealth reported revenue of $3.24B for fiscal 2025, down 0.49% from fiscal 2024.
AdaptHealth reported a net loss of $70.79M in fiscal 2025.
Annual revenue
| Fiscal year | Revenue | Growth | Net income | Net margin | EPS (diluted) | Free cash flow |
|---|---|---|---|---|---|---|
| FY2025ended Dec 31, 2025 | $3.24B | −0.5% | −$70.79M | −2.2% | −$0.52 | $219.38M |
| FY2024ended Dec 31, 2024 | $3.26B | +1.9% | $90.42M | 2.8% | $0.61 | $235.78M |
| FY2023ended Dec 31, 2023 | $3.20B | +7.7% | −$678.90M | −21.2% | −$5.31 | $143.20M |
| FY2022ended Dec 31, 2022 | $2.97B | +21.0% | $69.32M | 2.3% | $0.33 | −$17.56M |
| FY2021ended Dec 31, 2021 | $2.45B | +132.4% | $156.18M | 6.4% | $0.67 | $72.37M |
| FY2020ended Dec 31, 2020 | $1.06B | +99.5% | −$161.63M | −15.3% | −$3.08 | $155.88M |
| FY2019ended Dec 31, 2019 | $529.64M | +53.4% | −$21.34M | −4.0% | −$0.95 | $39.09M |
| FY2018ended Dec 31, 2018 | $345.28M | — | $23.26M | 6.7% | $1.95 | $58.48M |
| Quarter | Revenue | Net income | EPS (diluted) |
|---|---|---|---|
| Q2 FY2026ended Jun 30, 2026 | $740.31M | −$133.93M | −$0.99 |
| Q1 FY2026ended Mar 31, 2026 | $819.80M | −$16.04M | −$0.12 |
| Q4 FY2025ended Dec 31, 2025 | $989.56M | −$102.77M | −$0.73 |
| Q3 FY2025ended Sep 30, 2025 | $820.31M | $24.51M | $0.16 |
| Q2 FY2025ended Jun 30, 2025 | $657.10M | $14.67M | $0.10 |
| Q1 FY2025ended Mar 31, 2025 | $777.88M | −$7.21M | −$0.05 |
| Q4 FY2024ended Dec 31, 2024 | $856.65M | $50.26M | $0.35 |
| Q3 FY2024ended Sep 30, 2024 | $805.86M | $22.86M | $0.15 |
Company profile
- Name
- AdaptHealth Corp.
- Ticker
- AHCO
- Exchange
- NASDAQ
- Industry (SEC SIC)
- Services-Home Health Care Services
- Headquarters
- 555 East North Lane, Suite 5075, Conshohocken, PA 19428
- Incorporated in
- DE
- Fiscal year ends
- December
- SEC CIK
- 0001725255
Recent SEC filings
- Sep 8, 2026
- Aug 4, 2026
- Aug 4, 2026
- Jul 20, 2026
- Jul 7, 2026
- Jul 2, 2026
- Jun 22, 2026
- May 5, 2026
Frequently asked questions
What is AdaptHealth's stock price?
AdaptHealth (AHCO) closed at $213.78 on Oct 9, 2026, down 0.33% from the previous close of $214.48.
What is AdaptHealth's market cap?
AdaptHealth's market cap is $29.14B, based on a share price of $213.78 and 136.3M shares outstanding as of Jun 30, 2026.
How much revenue does AdaptHealth make?
AdaptHealth reported revenue of $3.24B for fiscal 2025, down 0.49% from fiscal 2024.
Does AdaptHealth pay a dividend?
AdaptHealth's recent filings report no dividends declared over the last four quarters.
Sources and methodology
Fundamentals come from AdaptHealth Corp.'s filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures